In den Warenkorb
Bestellen Sie auch über:
+49 (0)241 95 163 153
+49 (0)241 95 163 155

LC3 (APG8A) (N-term) Antikörper

Antigen

LC3 (APG8A) (N-term)

Klonalität Polyklonal
Wirt

Kaninchen

Reaktivität

Human, Ratte (Rattus)

Applikation
Western Blot (WB), Immunfluoreszenz (IF), Immunhistochemie (IHC), ELISA
2 Publikationen vorhanden
Zertifikate ISO 9001:2008
Produktnummer ABIN388464
Menge 0.1 mg  (0.25 mg/ml)
Preis 295,00 €   Zzgl. Versandkosten €20,00 und MWSt
Lieferung nach
Verfügbarkeit Lieferung in 7 bis 10 Werktagen

Produktbeschreibung

Produktmerkmale Purified Rabbit Polyclonal Antibody (Pab)
Gen-ID 84557
Swiss-Prot Q9H492
Immunogen This LC3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1~30 amino acids from the N-term of human LC3 (APG8a).
Isotyp Ig  (Passende Sekundärantikörper)
Beschreibung Other names: MAP1LC3A, microtubule-associated protein 1 light chain 3 alpha, RP11-346K17.1, LC3, LC3A, MAP1ALC3, MAP1BLC3, MAP1 light chain 3-like protein 1, MAP1A/1B light chain 3 A, MAP1A/MAP1B LC3 A, MAP1A/MAP1B light chain 3 A, OTTHUMP00000030698, autophagy-relate
Spezifität This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide at the N-term of human LC3 (APG8a).
Molekulargewicht 14272 DA

Anwendungen

Applikationshinweise The suggested dilution is: ELISA~~1:1,000 Western blotting~~1:100~500 Immunohistochemistry~~1:50~100 Immunofluorescent~~1:10~50
Konzentration 0.25 mg/ml
Reinigung Purified
Buffer Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Lagerung Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles
Forschungsgebiet Zelluläre Signaltransduktion, Zellstruktur, Autophagie
Beschränkungen Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen English, Chemali, Duron et al.: "Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection." in: Nature immunology, Vol. 10, Issue 5, pp. 480-7, 2009 (PubMed).

Cirstea, Hideshima, Rodig et al.: "Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma." in: Molecular cancer therapeutics, Vol. 9, Issue 4, pp. 963-75, 2010 (PubMed).